Editorial: Targeted Immunotherapy for Cancer.

Williams, Williams V

Williams, Williams V.

Affiliation

Williams WV; BriaCell Therapeutics Corp., Philadelphia, PA, United States.

Front Pharmacol ; 13: 894681, 2022.

Article in En | MEDLINE | ID: mdl-35496284

Key words

Cancer; Immune checkpoint inhibitor; Immune modulationimmunological terms; Immunotherapy; Targeted immunotherapy; targeted (selective) treatment

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041305
https://dx.doi.org/10.3389/fphar.2022.894681

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: United States

Fulltext

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9041305
https://dx.doi.org/10.3389/fphar.2022.894681

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2022 Document type: Article Affiliation country: United States